Latest news
Loading news…
Asklepios BioPharmaceutical
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Chapel Hill, North Carolina, United States Founded 2001 501-1000 employees For Profit
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Asklepios BioPharmaceutical was acquired by Bayer in 2020 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
3
Monthly Visits
Available in Pro Contacts
385
Patents
41
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 33
- Active products
- 18
- Patents granted
- 41
- Trademarks
- 1
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $422K
Company Info
- Founded
- 2001
- Employees
- 501-1000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 76
- HQ
- Chapel Hill, North Carolina, United States
- Region
- Research Triangle, East Coast, Southern US
- Diversity spotlight
- Women Founded; Women Led
- Exit date
- Oct 26, 2020
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -2.1
- Trend (90d)
- -2.2
- Last leadership hire
- Apr 4, 2025
Acquisitions by Asklepios BioPharmaceutical
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Asklepios BioPharmaceutical
Co-Founder
President, Chief Scientific Officer & Co-Founder
President
Chief Scientific Officer
Sr. Surgical Specialist
Chief Technology Officer
Chief Human Resources Officer
Head of Drug Development, CNS Gene Therapy
Sr. Vice President, Therapeutics
385
professional contacts at Asklepios BioPharmaceutical
Contact execs at Asklepios BioPharmaceutical →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Asklepios BioPharmaceutical
Loading news…
FAQs about Asklepios BioPharmaceutical
People who checked this page also checked these
Sectors Asklepios BioPharmaceutical invests & acquires in
Browse the full Acquirezy directory.